We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Synergy Pharmaceuticals

News List

Bausch Health makes $200m bid for bankrupt Synergy Pharmaceuticals pharmaceutical-technology
December 17, 2018
Canada-based Bausch Health Companies (previously Valeant Pharmaceuticals) has entered a definitive agreement to acquire select assets of Synergy Pharmaceuticals for around $200m and certain assumed liabilities.....
Bausch Health buy bankrupt Synergy Pharmaceuticals for $200m pharmafile
December 14, 2018
Bankrupt drug developer Synergy Pharmaceuticals has announced that the company is to be acquired by Canadian speciality pharma firm Bausch Health for approximately $200 million in cash.
Synergy Pharmaceuticals inks deal with Luxion Pharma biospectrumasia
August 13, 2018
The deal gives Luoxin exclusive rights to develop and commercialize Synergy’s lead product TRULANCE (plecanatide) for the treatment of adults with chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C) in mainland Chi